← FDA Drug Approvals (Drugs@FDA)

EPINEPHRINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2025-12-08

Drug application

FDA Application #

ANDA218208

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPINEPHRINE

Generic name

EPINEPHRINE

Active ingredients

EPINEPHRINE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

AMNEAL

Manufacturer

Amneal Pharmaceuticals Private Limited

First approval

2025-12-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown